Real-time, label-free monitoring of cytokine signatures in CAR T-cell therapy

Background

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a potent treatment for various hematological malignancies. This immunotherapy involves genetically modifying a patient’s T cells to target and kill cancer cells. Despite its promise, CAR T-cell therapy faces significant challenges due to the complex genetic landscape of cancers like B-cell acute lymphoblastic leukemia (B-ALL), which is marked by uncontrolled growth of immature lymphocytes. The inherent cellular heterogeneity within CAR T-cell populations and their varying cytokine secretomic profiles complicate the understanding and prediction of therapeutic outcomes. Addressing these challenges is crucial, as the heterogeneity in individual cell behaviors can significantly impact the therapy’s effectiveness and safety, making it essential to develop advanced analytical tools to study these variations at the single-cell level.

Current methods for analyzing immune responses, such as enzyme-linked immunoassay (ELISA), polymerase chain reaction (PCR), and intracytoplasmic cytokine staining (flow cytometry), are limited as they mainly provide bulk measurements and fail to capture the nuances of individual cell behaviors. Recent advancements in single-cell immunoassays, like barcode and microengraving techniques, offer multiparametric cytokine detection but are hindered by their static nature and laborious processing steps, which prevent real-time monitoring. Furthermore, technologies aimed at imaging secretory proteins, such as interferometric detection of scattered light (iSCAT), photonic crystal resonances (PhC), and total internal reflection fluorescence microscopy (TIRFM), lack the capability to visualize cytokine production and diffusion with the required spatiotemporal resolution. These limitations underscore the need for more sophisticated techniques that can provide real-time, high-resolution insights into single-cell cytokine secretomic dynamics and intercellular interactions, which are vital for improving the safety and efficacy of CAR T-cell therapies.

Technology

The nanoplasmon ruler is an advanced technology for real-time, label-free nanoplasmonic mapping of single-cell cytokine secretomic signatures, particularly in the context of CAR T-cell therapy. Designed using self-assembled metal nanoparticle (NP) dimers connected by aptamer-based linkers, this system leverages plasmonic coupling to achieve high spatiotemporal resolution in sensing cytokine secretion. The binding of cytokines like interleukin-6 (IL-6) and interferon-gamma (IFN-γ) to these aptamers induces conformational changes that alter the scattering light intensity, detectable via an electron-multiplying CCD (EMCCD) detector linked to a dark-field microscope. This setup enables the real-time visualization and mapping of cytokine secretion patterns from single cells, providing critical insights into cellular communication and cytokine secretion dynamics without the need for labels or washing steps.

What differentiates the nanoplasmon ruler lies in its ability to analyze cytokine secretion at an unprecedented single-cell level with high spatiotemporal resolution, revealing cellular heterogeneity and intercellular interactions. Traditional bulk measurement techniques such as enzyme-linked immunoassays (ELISA) and flow cytometry can measure overall immune responses but fail to capture the nuances of single-cell behavior. While recent single-cell immunoassays improve resolution, they often lack the capability for real-time monitoring. The nanoplasmon ruler overcomes these limitations by providing dynamic, real-time data on cytokine production, diffusion, and interaction among cells, such as CAR T cells, macrophages, and leukemia cells. This technology not only maps secretion anisotropy and diffusion coefficients but also elucidates complex immune interactions, thereby enhancing the understanding and optimization of CAR T-cell therapies and addressing challenges like cytokine release syndrome (CRS).

Benefits

• Enables real-time, label-free nanoplasmonic mapping of cytokine secretion with high sensitivity and spatiotemporal resolution.
• Simultaneous characterization of single-cell cytokine secretomic signatures.
• Visualizes complex, real-time cell-to-cell communication.
• Enhances understanding of CAR T-cell heterogeneity and cytokine secretomic signatures at the single-cell level.
• Facilitates the investigation of heterogeneous cytokine secretion patterns and crosstalk among CAR T cells, macrophages, and leukemia cells.
• Offers a potential avenue to enhance immunotherapy by illuminating foundational intercellular communication mechanisms within the immune system.
• Provides insights into cellular secretion behaviors and interactions, aiding in the refinement of CAR T-cell immunotherapy for optimized efficacy and safety in cancer treatment.
• Overcomes limitations of traditional methods by providing real-time monitoring without laborious labeling and washing steps.
• Delivers superior spatial resolution, enabling precise localization of cytokine binding events with heightened sensitivity and selectivity.
• Supports investigation of immune cell function and heterogeneity through high-resolution, real-time data on individual cytokine secretion patterns.

Applications

• CAR T-cell therapy enhancement
• Single-cell cytokine analysis
• Real-time immune response monitoring
• Cellular communication studies

Additional info

Label-free nanoplasmonic mapping technology uses a self-assembled nanoplasmon ruler to visualize real-time cytokine secretion from single immune cells. It enables in situ high-sensitivity and spatiotemporal resolution mapping of cytokines IL-6 and IFN-γ. This technique enhances the understanding of intercellular communication among CAR T cells, macrophages, and leukemia cells, providing insights into immune responses and improving CAR T-cell therapy efficacy and safety by elucidating single-cell cytokine secretion dynamics.